Related Experiment Videos
Alternative spliced transcripts as cancer markers
O L Caballero1, S J de Souza, R R Brentani
1Ludwig Institute for Cancer Research, São Paulo, Brazil.
Disease Markers
|October 24, 2001
Summary
Alternative splicing diversifies eukaryotic transcripts, expanding protein diversity and potentially explaining organism complexity. This process is implicated in cancer and may offer novel cancer markers.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Eukaryotic messenger RNAs (mRNAs) are initially transcribed with intronic sequences.
- Introns are removed, and exons are joined through splicing to create mature mRNAs.
- Alternative splicing generates transcript diversity from a limited gene set.
Purpose of the Study:
- To explore the role of alternative splicing in expanding protein repertoire.
- To investigate the significance of alternative splicing in cancer-associated genes.
- To assess the potential of alternatively spliced transcripts as cancer biomarkers.
Main Methods:
- Analysis of mRNA processing pathways.
- Identification of alternatively spliced gene products.
- Comparison of splicing patterns in normal versus tumor tissues.
Main Results:
- Alternative splicing significantly expands the proteome, potentially explaining eukaryotic complexity.
- Over 50% of human genes are alternatively spliced.
- Cancer-associated genes like CD44 and WT1 exhibit alternative splicing.
- Splicing variations are observed during tumor progression and may drive tumorigenesis.
Conclusions:
- Alternative splicing is a key mechanism for generating proteomic diversity.
- Aberrant alternative splicing plays a role in cancer development.
- Alternatively spliced transcripts show promise as sensitive and specific cancer markers due to differential usage in tumor versus normal tissues.